IKK/NF-κB signaling: balancing life and death -: a new approach to cancer therapy

被引:725
作者
Luo, JL [1 ]
Kamata, H [1 ]
Karin, M [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol & Canc Ctr, La Jolla, CA 92093 USA
关键词
D O I
10.1172/JCI26322
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1KB kinase/NF-KB (IkK/NF-KB) signaling pathways play critical roles in a variety of physiological and pathological processes. One function of NF-KB is promotion of cell survival through induction of target genes, whose products inhibit components of the apoptotic machinery in normal and cancerous cells. NF-KB can also prevent programmed necrosis by inducing genes encoding antioxidant proteins. Regardless of mechanism, many cancer cells, of either epithelial or hematopoietic origin. use NF-KB to achieve resistance to anticancer drugs, radiation, and death cytokines. Hence, inhibition of IKK-driven NF-KB activation offers a strategy for treatment of different malignancies and can convert inflammation-induced tumor growth to inflammation-induced tumor regression.
引用
收藏
页码:2625 / 2632
页数:8
相关论文
共 119 条
[61]   Broad-spectrum caspase inhibition paradoxically augments cell death in TNF-α-stimulated neutrophils [J].
Liu, CY ;
Takemasa, A ;
Liles, WC ;
Goodman, RB ;
Jonas, M ;
Rosen, H ;
Chi, E ;
Winn, RK ;
Harlan, JM ;
Chuang, PI .
BLOOD, 2003, 101 (01) :295-304
[62]   Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression [J].
Luo, JL ;
Maeda, S ;
Hsu, LC ;
Yagita, H ;
Karin, M .
CANCER CELL, 2004, 6 (03) :297-305
[63]   Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors [J].
Luo, X ;
Budihardjo, I ;
Zou, H ;
Slaughter, C ;
Wang, XD .
CELL, 1998, 94 (04) :481-490
[64]   IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis [J].
Maeda, S ;
Kamata, H ;
Luo, JL ;
Leffert, H ;
Karin, M .
CELL, 2005, 121 (07) :977-990
[65]   IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα [J].
Maeda, S ;
Chang, LF ;
Li, ZW ;
Luo, JL ;
Leffert, H ;
Karin, M .
IMMUNITY, 2003, 19 (05) :725-737
[66]   Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti [J].
Makris, C ;
Godfrey, VL ;
Krähn-Senftleben, G ;
Takahashi, T ;
Roberts, JL ;
Schwarz, T ;
Feng, LL ;
Johnson, RS ;
Karin, M .
MOLECULAR CELL, 2000, 5 (06) :969-979
[67]   Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B [J].
Meng, TC ;
Buckley, DA ;
Galic, S ;
Tiganis, T ;
Tonks, NK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (36) :37716-37725
[68]   Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo [J].
Meng, TC ;
Fukada, T ;
Tonks, NK .
MOLECULAR CELL, 2002, 9 (02) :387-399
[69]   Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes [J].
Micheau, O ;
Tschopp, J .
CELL, 2003, 114 (02) :181-190
[70]   Blocking anti-apoptosis as a strategy for cancer chemotherapy:: NF-κB as a target [J].
Monks, NR ;
Biswas, DK ;
Pardee, AB .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (04) :646-650